MicroTransponder Raises $53M, Appoints New CEO

AUSTIN, Texas, June 20, 2022 -- (Healthcare Sales & Marketing Network) -- MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and Exceller H... Devices, Neurology, Personnel, Venture Capital MicroTransponder, Vivistim, stroke
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news